Canadian Pharmacy Blog

The FDA has approved a New Drug Application (NDA) for omeprazole (Zegerid™ Powder for Oral Suspension, Santarus) 40 mg to reduce the risk of upper gastrointestinal bleeding in critically ill patients and for the short-term treatment of active benign gastric ulcers. An immediate-release oral proton-pump inhibitor (PPI), the powder is the only PPI approved for [...]

Among different proton pump inhibitors ( PPIs ) using in patients with gastroesophageal reflux disease (GERD), one medication has more pharmacological and clinical advantages. It is Esomeprazole (Nexium drug) that gives relief in patients with reflux esophagitis. But at this moment we can’t clearly say if differences in the attack of antisecretory activity can influence [...]